IKS-02

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIKS-02
Drug Alias NameIKS-02
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionCyclin-dependent kinase inhibitorsImmunomodulators
TargetsCyclin-dependent kinase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIksuda Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesIksuda Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A